AK

Amit Kaushik

Director Director DIN 01282508
DIN 01282508 First appointment Oct 2006 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2006
Shareholding value Locked Premium profile

About Amit Kaushik

Data last updated:

Amit Kaushik has 19 years in corporate governance. Formerly with 1 company, such as Winston Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01282508
Primary Designation Director
First Appointment 12 Oct 2006
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Winston Pharmaceuticals Limited U24231MH1996PLC360820
Director12 Oct 20061996Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Winston Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Amit Kaushik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Kaushik

Amit Kaushik has 19 years in corporate governance. Formerly with 1 company, such as Winston Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

Amit Kaushik is associated with 0 companies as a director.

Amit Kaushik has expertise in General Business.

Amit Kaushik has 19 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available